4.7 Review

Glutamate receptors and persistent pain: targeting forebrain NR2B subunits

期刊

DRUG DISCOVERY TODAY
卷 7, 期 4, 页码 259-267

出版社

ELSEVIER SCI LTD
DOI: 10.1016/S1359-6446(01)02138-9

关键词

-

资金

  1. NIDA NIH HHS [DA10833] Funding Source: Medline
  2. NINDS NIH HHS [NS38680] Funding Source: Medline

向作者/读者索取更多资源

Glutamate is the fast excitatory transmitter in mammalian brains. It binds to two major classes of glutamate receptors: ionotropic and metabotropic receptors. lonotropic receptors contain three subtype receptors, including N-methyl-D-aspartate (NMDA) receptors. Activation of NMDA receptors is important for initiating long-lasting changes in synapses. In the forebrain structures that are known to contribute to the formation and storage of information, NMDA receptors have an important role in persistent inflammatory pain by reinforcing glutamate sensory transmission. Mice with enhanced forebrain NMDA receptor function demonstrate selective enhancement of persistent pain and allodynia. Drugs targeting NMDA NR2B subunits in the forebrain could serve as a new class of medicine for controlling persistent pain in humans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据